Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Topical local anesthesia: focus on lidocaine-tetracaine combination.

Giordano D, Raso MG, Pernice C, Agnoletti V, Barbieri V.

Local Reg Anesth. 2015 Nov 27;8:95-100. doi: 10.2147/LRA.S41836. eCollection 2015. Review.

2.

Nutritional parameters predicting pressure ulcers and short-term mortality in patients with minimal conscious state as a result of traumatic and non-traumatic acquired brain injury.

Montalcini T, Moraca M, Ferro Y, Romeo S, Serra S, Raso MG, Rossi F, Sannita WG, Dolce G, Pujia A.

J Transl Med. 2015 Sep 17;13:305. doi: 10.1186/s12967-015-0660-4.

3.

A rare case of spontaneous cricothyroid joint dislocation.

Pernice C, Giordano D, Menichetti M, Raso MG, Barbieri V.

Auris Nasus Larynx. 2016 Apr;43(2):200-2. doi: 10.1016/j.anl.2015.07.006. Epub 2015 Aug 19.

PMID:
26298232
4.

Improving laboratory test ordering can reduce costs in surgical wards.

Giordano D, Zasa M, Iaccarino C, Vincenti V, Dascola I, Brevi BC, Gherli T, Raso MG, Campaniello G, Bonelli P, Vezzani A.

Acta Biomed. 2015 Apr 27;86(1):32-7.

PMID:
25948025
5.

Unusual presentation of pediatric acute sphenoid sinusitis.

Giordano D, Perano D, Marchi S, Raso MG, Barbieri V.

Acta Biomed. 2014 Dec 17;85(3):271-4.

PMID:
25567465
6.

Neurologic toxicity of lidocaine during awake intubation in a patient with tongue base abscess. Case report.

Giordano D, Panini A, Pernice C, Raso MG, Barbieri V.

Am J Otolaryngol. 2014 Jan-Feb;35(1):62-5. doi: 10.1016/j.amjoto.2013.08.009. Epub 2013 Oct 10.

PMID:
24120692
7.

Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma.

Wistuba II, Behrens C, Lombardi F, Wagner S, Fujimoto J, Raso MG, Spaggiari L, Galetta D, Riley R, Hughes E, Reid J, Sangale Z, Swisher SG, Kalhor N, Moran CA, Gutin A, Lanchbury JS, Barberis M, Kim ES.

Clin Cancer Res. 2013 Nov 15;19(22):6261-71. doi: 10.1158/1078-0432.CCR-13-0596. Epub 2013 Sep 18.

8.

Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.

Guo C, Shao R, Correa AM, Behrens C, Johnson FM, Raso MG, Prudkin L, Solis LM, Nunez MI, Fang B, Roth JA, Wistuba II, Swisher SG, Lin T, Pataer A.

J Thorac Oncol. 2013 Mar;8(3):301-8. doi: 10.1097/JTO.0b013e318282def7.

9.

Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy.

Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG; University of Texas M. D. Anderson Lung Cancer Collaborative Research Group.

J Thorac Oncol. 2012 May;7(5):825-32. doi: 10.1097/JTO.0b013e318247504a.

10.

The role of PKR/eIF2α signaling pathway in prognosis of non-small cell lung cancer.

He Y, Correa AM, Raso MG, Hofstetter WL, Fang B, Behrens C, Roth JA, Zhou Y, Yu L, Wistuba II, Swisher SG, Pataer A.

PLoS One. 2011;6(11):e24855. doi: 10.1371/journal.pone.0024855. Epub 2011 Nov 10.

11.

Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.

Solis LM, Behrens C, Raso MG, Lin HY, Kadara H, Yuan P, Galindo H, Tang X, Lee JJ, Kalhor N, Wistuba II, Moran CA.

Cancer. 2012 Jun 1;118(11):2889-99. doi: 10.1002/cncr.26584. Epub 2011 Oct 21.

12.

Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion.

Moussalli MJ, Wu Y, Zuo X, Yang XL, Wistuba II, Raso MG, Morris JS, Bowser JL, Minna JD, Lotan R, Shureiqi I.

Cancer Prev Res (Phila). 2011 Dec;4(12):1961-72. doi: 10.1158/1940-6207.CAPR-10-0280. Epub 2011 Aug 31.

13.

Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy.

Yang F, Tang X, Riquelme E, Behrens C, Nilsson MB, Giri U, Varella-Garcia M, Byers LA, Lin HY, Wang J, Raso MG, Girard L, Coombes K, Lee JJ, Herbst RS, Minna JD, Heymach JV, Wistuba II.

Cancer Res. 2011 Aug 15;71(16):5512-21. doi: 10.1158/0008-5472.CAN-10-2614. Epub 2011 Jul 1.

14.

Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases.

Tsuta K, Kalhor N, Raso MG, Wistuba II, Moran CA.

Hum Pathol. 2011 Apr;42(4):578-85. doi: 10.1016/j.humpath.2009.10.030. Epub 2011 Feb 16.

PMID:
21329962
15.

Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung.

Tsuta K, Raso MG, Kalhor N, Liu DC, Wistuba II, Moran CA.

Histopathology. 2011 Jan;58(2):276-85. doi: 10.1111/j.1365-2559.2011.03747.x.

PMID:
21323953
16.

Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.

Nanjundan M, Byers LA, Carey MS, Siwak DR, Raso MG, Diao L, Wang J, Coombes KR, Roth JA, Mills GB, Wistuba II, Minna JD, Heymach JV.

J Thorac Oncol. 2010 Dec;5(12):1894-904. doi: 10.1097/JTO.0b013e3181f2a266.

17.

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.

Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, Honorio S, Xie Y, Scaglioni PP, DiMaio JM, Gazdar AF, Shay JW, Wistuba II, Minna JD.

Cancer Res. 2010 Dec 1;70(23):9937-48. doi: 10.1158/0008-5472.CAN-10-0881. Epub 2010 Nov 30.

18.

Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients.

Pataer A, Raso MG, Correa AM, Behrens C, Tsuta K, Solis L, Fang B, Roth JA, Wistuba II, Swisher SG.

Clin Cancer Res. 2010 Nov 15;16(22):5522-8. doi: 10.1158/1078-0432.CCR-10-0753. Epub 2010 Oct 7.

19.

Effective drug delivery, in vitro and in vivo, by carbon-based nanovectors noncovalently loaded with unmodified Paclitaxel.

Berlin JM, Leonard AD, Pham TT, Sano D, Marcano DC, Yan S, Fiorentino S, Milas ZL, Kosynkin DV, Price BK, Lucente-Schultz RM, Wen X, Raso MG, Craig SL, Tran HT, Myers JN, Tour JM.

ACS Nano. 2010 Aug 24;4(8):4621-36. doi: 10.1021/nn100975c. Erratum in: ACS Nano. 2010 Sep 28;4(9):5512.

20.

Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.

Cai D, Shames DS, Raso MG, Xie Y, Kim YH, Pollack JR, Girard L, Sullivan JP, Gao B, Peyton M, Nanjundan M, Byers L, Heymach J, Mills G, Gazdar AF, Wistuba I, Kodadek T, Minna JD.

Cancer Res. 2010 Aug 15;70(16):6477-85. doi: 10.1158/0008-5472.CAN-10-0005. Epub 2010 Jul 27.

21.

Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer.

Byers LA, Holsinger FC, Kies MS, William WN, El-Naggar AK, Lee JJ, Hu J, Lopez A, Tran HT, Yan S, Du Z, Ang KK, Glisson BS, Raso MG, Wistuba II, Myers JN, Hong WK, Papadimitrakopoulou V, Lippman SM, Heymach JV.

Mol Cancer Ther. 2010 Jun;9(6):1755-63. doi: 10.1158/1535-7163.MCT-09-1047. Epub 2010 Jun 8.

22.

Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.

Tsuta K, Raso MG, Kalhor N, Liu DD, Wistuba II, Moran CA.

Lung Cancer. 2011 Jan;71(1):34-41. doi: 10.1016/j.lungcan.2010.04.007. Epub 2010 May 11.

PMID:
20462655
23.

Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases.

Solis LM, Raso MG, Kalhor N, Behrens C, Wistuba II, Moran CA.

Am J Clin Pathol. 2010 Jan;133(1):133-40. doi: 10.1309/AJCPOQWPT1T1AJFT.

PMID:
20023269
24.

Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.

Jin N, Cho SN, Raso MG, Wistuba I, Smith Y, Yang Y, Kurie JM, Yen R, Evans CM, Ludwig T, Jeong JW, DeMayo FJ.

Development. 2009 Oct;136(19):3347-56. doi: 10.1242/dev.032979. Epub 2009 Aug 26.

25.

Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.

Raso MG, Behrens C, Herynk MH, Liu S, Prudkin L, Ozburn NC, Woods DM, Tang X, Mehran RJ, Moran C, Lee JJ, Wistuba II.

Clin Cancer Res. 2009 Sep 1;15(17):5359-68. doi: 10.1158/1078-0432.CCR-09-0033. Epub 2009 Aug 25.

26.

Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma.

Gibbons DL, Lin W, Creighton CJ, Zheng S, Berel D, Yang Y, Raso MG, Liu DD, Wistuba II, Lozano G, Kurie JM.

PLoS One. 2009;4(4):e5401. doi: 10.1371/journal.pone.0005401. Epub 2009 Apr 30.

27.

Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells.

Zhang J, Iwanaga K, Choi KC, Wislez M, Raso MG, Wei W, Wistuba II, Kurie JM.

Cancer Prev Res (Phila). 2008 Aug;1(3):201-7. doi: 10.1158/1940-6207.CAPR-08-0014. Epub 2008 Mar 31.

28.

HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.

Perera SA, Li D, Shimamura T, Raso MG, Ji H, Chen L, Borgman CL, Zaghlul S, Brandstetter KA, Kubo S, Takahashi M, Chirieac LR, Padera RF, Bronson RT, Shapiro GI, Greulich H, Meyerson M, Guertler U, Chesa PG, Solca F, Wistuba II, Wong KK.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):474-9. doi: 10.1073/pnas.0808930106. Epub 2009 Jan 2.

29.

Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.

Behrens C, Lin HY, Lee JJ, Raso MG, Hong WK, Wistuba II, Lotan R.

Clin Cancer Res. 2008 Oct 1;14(19):6014-22. doi: 10.1158/1078-0432.CCR-08-0167.

30.

Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer.

Yang Y, Iwanaga K, Raso MG, Wislez M, Hanna AE, Wieder ED, Molldrem JJ, Wistuba II, Powis G, Demayo FJ, Kim CF, Kurie JM.

PLoS One. 2008 May 21;3(5):e2220. doi: 10.1371/journal.pone.0002220.

31.

Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.

Iwanaga K, Yang Y, Raso MG, Ma L, Hanna AE, Thilaganathan N, Moghaddam S, Evans CM, Li H, Cai WW, Sato M, Minna JD, Wu H, Creighton CJ, Demayo FJ, Wistuba II, Kurie JM.

Cancer Res. 2008 Feb 15;68(4):1119-27. doi: 10.1158/0008-5472.CAN-07-3117.

Supplemental Content

Support Center